Corporate Event Transcript Instant Alerts Corporate Event Transcript Instant Alerts - Page 4 September 20, 2026 4:02 PM ETJazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1BMarketBeatNASDAQ:JAZZRead Jazz Pharmaceuticals Targets $5B Zanidatamab Opportunity as Oncology Revenue Tops $1BSeptember 20, 2026 3:01 PM ETWW International Eyes Cash Flow Turnaround as GLP-1 Care Gains MomentumMarketBeatNASDAQ:WWRead WW International Eyes Cash Flow Turnaround as GLP-1 Care Gains MomentumSeptember 20, 2026 2:02 PM ETJazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline ExpandsMarketBeatNASDAQ:JAZZRead Jazz Pharmaceuticals Sees $3B-$5B Ziihera Opportunity as Pipeline ExpandsSeptember 20, 2026 1:02 PM ETStanley Black & Decker Targets Margin Gains as DEWALT Takes ShareMarketBeatNYSE:SWKRead Stanley Black & Decker Targets Margin Gains as DEWALT Takes ShareSeptember 20, 2026 12:02 PM ETSynchrony Financial Sees Resilient Spending, Reaffirms Receivables Growth OutlookMarketBeatNYSE:SYFRead Synchrony Financial Sees Resilient Spending, Reaffirms Receivables Growth OutlookSeptember 20, 2026 11:01 AM ETLexicon Completes SONATA-HCM Enrollment, Eyes 2027 Sotagliflozin DataMarketBeatNASDAQ:LXRXRead Lexicon Completes SONATA-HCM Enrollment, Eyes 2027 Sotagliflozin DataSeptember 20, 2026 10:02 AM ETAlnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue OutlookMarketBeatNASDAQ:ALNYRead Alnylam Highlights AMVUTTRA Momentum, Resets 2026 TTR Revenue OutlookSeptember 20, 2026 9:02 AM ETIDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth TargetsMarketBeatNASDAQ:IDXXRead IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth TargetsSeptember 20, 2026 8:02 AM ETIDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley ConferenceMarketBeatNASDAQ:IDXXRead IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley ConferenceSeptember 20, 2026 7:02 AM ETDICK’S Sporting Goods Sees Healthy Demand as Foot Locker Turnaround Takes LongerMarketBeatNYSE:DKSRead DICK’S Sporting Goods Sees Healthy Demand as Foot Locker Turnaround Takes LongerSeptember 20, 2026 6:02 AM ETRegions Financial Eyes 150 New Branches as Deposit Strength Supports GrowthMarketBeatNYSE:RFRead Regions Financial Eyes 150 New Branches as Deposit Strength Supports GrowthSeptember 20, 2026 5:02 AM ETPrologis Sees Leasing Surge, Data Centers Fuel Growth OutlookMarketBeatNYSE:PLDRead Prologis Sees Leasing Surge, Data Centers Fuel Growth OutlookSeptember 20, 2026 4:02 AM ETCrocs Touts Product Innovation, HEYDUDE Reset and Wholesale Demand Green ShootsMarketBeatNASDAQ:CROXRead Crocs Touts Product Innovation, HEYDUDE Reset and Wholesale Demand Green ShootsSeptember 20, 2026 3:02 AM ETGenuine Parts Maps Motion Spinoff as Automotive Unit Modernizes Supply ChainMarketBeatNYSE:GPCRead Genuine Parts Maps Motion Spinoff as Automotive Unit Modernizes Supply ChainSeptember 20, 2026 2:01 AM ETSanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent LossMarketBeatNASDAQ:SNYRead Sanofi Eyes €25B Dupixent Future, Expands M&A Hunt Ahead of Patent LossSeptember 20, 2026 12:02 AM ETPacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing PushMarketBeatNASDAQ:PACBRead Pacific Biosciences Targets Clinical Growth, $40M Savings With HiFi Sequencing PushSeptember 19, 2026 11:02 PM ETCentene Reaffirms 2026 EPS Outlook as Medicaid Membership Decline DeepensMarketBeatNYSE:CNCRead Centene Reaffirms 2026 EPS Outlook as Medicaid Membership Decline DeepensSeptember 19, 2026 10:02 PM ETRoyal Bank of Canada Highlights 18% ROE, HSBC Synergies and U.S. GrowthMarketBeatNYSE:RYRead Royal Bank of Canada Highlights 18% ROE, HSBC Synergies and U.S. GrowthSeptember 19, 2026 9:02 PM ETRockwell Automation Sees Data Centers, Labor Crunch Fueling Automation DemandMarketBeatNYSE:ROKRead Rockwell Automation Sees Data Centers, Labor Crunch Fueling Automation DemandSeptember 19, 2026 8:02 PM ETIncyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales TargetMarketBeatNASDAQ:INCYRead Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales TargetSeptember 19, 2026 7:01 PM ETAlnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH TrialMarketBeatNASDAQ:ALNYRead Alnylam’s Zilebesiran Targets Twice-Yearly Blood Pressure Control in ZENITH TrialSeptember 19, 2026 6:02 PM ETBrookfield Asset Management Targets Doubling Fee-Bearing Capital by 2031MarketBeatNYSE:BAMRead Brookfield Asset Management Targets Doubling Fee-Bearing Capital by 2031September 19, 2026 5:02 PM ETDefinium Therapeutics’ DT120 Hits Phase III Goals in Anxiety StudyMarketBeatNASDAQ:DFTXRead Definium Therapeutics’ DT120 Hits Phase III Goals in Anxiety StudySeptember 19, 2026 4:01 PM ETCardinal Health Targets 13%-15% EPS Growth as Specialty Momentum BuildsMarketBeatNYSE:CAHRead Cardinal Health Targets 13%-15% EPS Growth as Specialty Momentum BuildsSeptember 19, 2026 3:02 PM ETBNY Sees Cross-Selling and AI Investments Fueling Its Next Growth PhaseMarketBeatNYSE:BNYRead BNY Sees Cross-Selling and AI Investments Fueling Its Next Growth PhaseSeptember 19, 2026 2:02 PM ETEquinix Sees AI Driving Data Center Demand, Interconnection GrowthMarketBeatNASDAQ:EQIXRead Equinix Sees AI Driving Data Center Demand, Interconnection Growth Page 4 of 4 « Most Recent‹ More Recent1234 More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
